Most Popular
|
Newsletter
|
| Cyagen CEO Lance Han - Pushing Therapeutic Advances Through Modelling |
| Apr 24, 2023 |
| Cyagen Biosciences CEO Lance Han was recently featured in an interview with CEO Insights Asia Magazine. In the interview, Han discussed his vision for the future of biotech and gene editing and shared insights on how Cyagen is pioneering innovation in cell and gene therapy research through data-driven solutions. Additionally, Han was recognized by the magazine as one of the TOP 10 TSINGHUA UNIVERSITY ALUMNI LEADERS - 2023, a prestigious accolade that showcases his exceptional leadership skills and contributions to the biotech industry. Read More > |
|
Research Trends
|
| Frequently Asked Questions (FAQ) on Mouse Models for Ophthalmic Diseases |
| Apr 21, 2023 |
| Due to the limited efficacy of traditional treatments, ophthalmic diseases have quickly become a breakthrough point for gene therapy, but many questions about mouse models for preclinical ophthalmology research remain. Read More > |
|
Research Trends
|
| Revolutionizing Neovascular Ophthalmology Research: Cyagen's Phenotypically Stable Humanized VEGF Mice |
| Apr 13, 2023 |
| As a popular target for treating diseases like macular degeneration and tumors, vascular endothelial growth factor (VEGF) has already had several drugs approved for clinical use and has made significant progress. In February of this year, researchers completed the first Phase I clinical trial of a recombinant anti-VEGFA and VEGFC bispecific antibody fusion protein in a for age-related macular degeneration with neovascularization. Read More > |
|
Research Trends
|
| Humanized VEGFA Mouse Models for Preclinical Wet AMD Ophthalmology Research |
| Mar 30, 2023 |
| Recently, researchers announced that they have found a new target for inhibiting vascular endothelial growth factor (VEGF), which can improve the symptoms of ophthalmic diseases. This is achieved by affecting the release of VEGF and choroidal neovascularization through fat mass and obesity-associated protein (FTO) inhibition. Read More > |
|
Research Trends
|
| Applications of iPSC-based Disease Models |
| Feb 16, 2023 |
| Induced pluripotent stem cells (iPSCs) provide an ideal in vitro platform for studying disease mechanisms and developing cell therapy approaches, as they can be derived from cells with a singular genetic background and tailored to replicate specific disease phenotypes. Read More > |
|
Research Trends
|
| What is Autism Spectrum Disorder (ASD) and what are the gene-edited mouse models for autism? |
| Jan 29, 2023 |
| Autism Spectrum Disorder (ASD) refers to a broad range of complex neurodevelopmental conditions that has many theorized causative factors, but there have been many genetic mutations associated with susceptibility to autism and altered brain structure associated with ASD. Read More > |
|
Research Trends
|
| How Much Do You Know About The Behavioral Differences Between Rats And Mice? |
| Jan 16, 2023 |
| Murine genomes share great similarity with the human genome, which has made both mice and rats fantastic models for a wide range human disease research. Read More > |
|
Research Trends
|
| The Morris Water Maze: Illustrated Handbook for Researchers |
| Jan 10, 2023 |
| The Morris water maze is a widely used task in behavioral neuroscience for the study of spatial learning and memory, while additionally testing endurance and physical strength. Read More > |
|
Research Trends
|
| Y Maze Behavioral Task: Studying the function of spatial learning and memory in Neuroscience research |
| Dec 29, 2022 |
| Since animals can't speak, they can't tell you whether they remember what just happened, or what they are experiencing at this moment. The most direct way to understand what they are thinking is to observe their behaviors. Read More > |
|
Q&A
|
| CAR Cell Therapy Research Models: Conversation with The Experts |
| Dec 22, 2022 |
| Animal models play an important role in the preclinical evaluation of cancer immunotherapy. Let's hear from the experts from Cyagen! Read More > |
